Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma

NCT00005074

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada
  • Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada
  • Toronto General Hospital Toronto, Ontario, Canada
  • Humber River Regional Hospital Weston, Ontario, Canada
View Trial Details
Completed

Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation

NCT00031668

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +30 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
  • Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada
View Trial Details
Completed

Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma

NCT00064116

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
  • The Moncton Hospital Moncton, New Brunswick, Canada
View all 25 locations
View Trial Details
Completed

Investigating the Effect of Deep Sea Krill Oil Supplementation in Osteoarthritis of the Knee

NCT03483090

Conditions
Arthritis, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • University of the Sunshine Coast Clinical Trials Centre, Morayfield Health Hub Morayfield, Queensland, Australia
  • University of the Sunshine Coast Clinical Trials Centre, USC Health Clinics Sippy Downs, Queensland, Australia
  • CSIRO Nutrition and Health Research Clinic Adelaide, South Australia, Australia
  • Emeritus Research Camberwell, Victoria, Australia
View Trial Details
Completed

A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma

NCT00211185

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Birmingham Hematology and Oncology Birmingham, Alabama, United States
  • Hematology Oncology Associates Phoenix, Arizona, United States
  • Stanford Cancer Center Stanford, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
View all 49 locations
View Trial Details
Completed

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

NCT00918333

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +75 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mark O Hatfield-Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma

NCT02296164

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Investigator Site Little Rock, Arkansas, United States
  • Investigator Site Duarte, California, United States
  • Investigator Site La Mesa, California, United States
  • Investigator Site San Francisco, California, United States
View all 36 locations
View Trial Details
Completed

A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies

NCT03106428

Conditions
Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
View all 14 locations
View Trial Details

Related conditions